Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2014

Open Access 01-10-2014 | Original Article

Somatostatin Inhibits the Production of Interferon-γ by Intestinal Epithelial Cells During Intestinal Ischemia–Reperfusion in Macaques

Authors: Ling Liu, Qinghua Tan, Bin Hu, Hao Wu, Chunhui Wang, Chengwei Tang

Published in: Digestive Diseases and Sciences | Issue 10/2014

Login to get access

Abstract

Background

Our previous study found that somatostatin (SST) inhibited the intestinal inflammatory injury in a macaque model of intestinal ischemia–reperfusion (IIR); however, the underlying mechanism was unclear.

Aims

The present study was aimed to investigate the effects of SST on IFN-γ and the systemic inflammatory response after IIR.

Methods

Fifteen macaques were randomly divided into controls, IIR and SST+ IIR groups. ELISA was performed to measure IFN-γ in ileum tissues, ileac epithelial cells (IECs) and ileal lymphocytes, as well as the systemic levels of IL-6, IL-1β, TNF-α and IFN-γ in the peripheral circulation and the portal vein. HE staining was performed to evaluate morphological changes in vital organs. Immunohistochemistry was performed to identify the distribution of IFN-γ, CD4, CD8 and CD57 in the ileum.

Results

After IIR, IFN-γ level was significantly increased in the IECs. IL-6, IL-1β and TNF-α were significantly increased in both the portal vein and the peripheral circulation; in contrast, IFN-γ level was increased in the portal vein alone. Prophylactic SST reversed the change in IFN-γ in the IECs and portal vein. SST led to an alleviation of the pathological changes in systemic vital organs. The distribution of CD4+, CD57+ and CD8+ cells was not positively correlated with the secretion of IFN-γ.

Conclusion

IECs are the main source of IFN-γ production after IIR. SST may indirectly lead to mast cell deactivation through the inhibition of IFN-γ production by IECs. Pretreatment with SST may be beneficial for preventing a massive systemic inflammatory response in vital organs after IIR.
Literature
1.
go back to reference American gastroenterological association medical position statement: guidelines on intestinal ischemia. Gastroenterology. 2000;118:951–953. American gastroenterological association medical position statement: guidelines on intestinal ischemia. Gastroenterology. 2000;118:951–953.
2.
go back to reference Puleo F, Arvanitakis M, Van Gossum A, Preiser JC. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32:626–638.PubMedCrossRef Puleo F, Arvanitakis M, Van Gossum A, Preiser JC. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32:626–638.PubMedCrossRef
3.
go back to reference Rotstein OD. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination. Surg Infect. 2000;1:217–223; discussion 223–225. Rotstein OD. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination. Surg Infect. 2000;1:217–223; discussion 223–225.
4.
go back to reference Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock. 2007;28:384–393.PubMedCrossRefPubMedCentral Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock. 2007;28:384–393.PubMedCrossRefPubMedCentral
6.
go back to reference Ramsay DB, Stephen S, Borum M, Voltaggio L, Doman DB. Mast cells in gastrointestinal disease. Gastroenterol Hepatol. 2010;6:772–777. Ramsay DB, Stephen S, Borum M, Voltaggio L, Doman DB. Mast cells in gastrointestinal disease. Gastroenterol Hepatol. 2010;6:772–777.
7.
go back to reference Huber M. Microfilaments make mast cells migrate (rather than degranulate). Eur J Immunol. 2013;43:1698–1701. Huber M. Microfilaments make mast cells migrate (rather than degranulate). Eur J Immunol. 2013;43:1698–1701.
8.
go back to reference Tang CW, Lan C, Liu R. Increased activity of the intestinal mucosal mast cells in rats with multiple organ failure. Chin J Dig Dis. 2004;5:81–86.PubMedCrossRef Tang CW, Lan C, Liu R. Increased activity of the intestinal mucosal mast cells in rats with multiple organ failure. Chin J Dig Dis. 2004;5:81–86.PubMedCrossRef
9.
go back to reference Tang C, Lan C, Wang C, Liu R. Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock. 2005;23:470–475.PubMedCrossRef Tang C, Lan C, Wang C, Liu R. Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock. 2005;23:470–475.PubMedCrossRef
10.
go back to reference Saavedra Y, Vergara P. Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia. Regul Pept. 2003;111:67–75.PubMedCrossRef Saavedra Y, Vergara P. Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia. Regul Pept. 2003;111:67–75.PubMedCrossRef
11.
go back to reference Wu H, Liu L, Tan Q, et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. J Gastrointest Surg. 2009;13:983–993.PubMedCrossRef Wu H, Liu L, Tan Q, et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. J Gastrointest Surg. 2009;13:983–993.PubMedCrossRef
12.
go back to reference Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41–101.PubMedCrossRef Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41–101.PubMedCrossRef
13.
go back to reference Ito R, Shin-Ya M, Kishida T, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol. 2006;146:330–338.PubMedCrossRefPubMedCentral Ito R, Shin-Ya M, Kishida T, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol. 2006;146:330–338.PubMedCrossRefPubMedCentral
14.
go back to reference Nava P, Koch S, Laukoetter MG, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32:392–402.PubMedCrossRefPubMedCentral Nava P, Koch S, Laukoetter MG, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32:392–402.PubMedCrossRefPubMedCentral
15.
go back to reference Schoeler D, Grutzkau A, Henz BM, Kuchler J, Kruger-Krasagakis S. Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. J Invest Dermatol. 2003;120:795–801.PubMedCrossRef Schoeler D, Grutzkau A, Henz BM, Kuchler J, Kruger-Krasagakis S. Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. J Invest Dermatol. 2003;120:795–801.PubMedCrossRef
16.
go back to reference Eastmond NC, Banks EM, Coleman JW. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. J Immunol. 1997;159:1444–1450.PubMed Eastmond NC, Banks EM, Coleman JW. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. J Immunol. 1997;159:1444–1450.PubMed
17.
go back to reference Wills FL, Gilchrist M, Befus AD. Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide. Immunology. 1999;97:481–489.PubMedCrossRefPubMedCentral Wills FL, Gilchrist M, Befus AD. Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide. Immunology. 1999;97:481–489.PubMedCrossRefPubMedCentral
18.
go back to reference Yu M, Eckart MR, Morgan AA, et al. Identification of an IFN-gamma/mast cell axis in a mouse model of chronic asthma. J Clin Investig. 2011;121:3133–3143.PubMedCrossRefPubMedCentral Yu M, Eckart MR, Morgan AA, et al. Identification of an IFN-gamma/mast cell axis in a mouse model of chronic asthma. J Clin Investig. 2011;121:3133–3143.PubMedCrossRefPubMedCentral
19.
go back to reference Yanagida M, Fukamachi H, Takei M, et al. Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells. Immunology. 1996;89:547–552.PubMedCrossRefPubMedCentral Yanagida M, Fukamachi H, Takei M, et al. Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells. Immunology. 1996;89:547–552.PubMedCrossRefPubMedCentral
20.
go back to reference Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;49:593–598.PubMedCrossRef Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;49:593–598.PubMedCrossRef
21.
go back to reference Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath MF. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007;2:2307–2311.PubMedCrossRef Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath MF. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007;2:2307–2311.PubMedCrossRef
22.
go back to reference Lefrançois L, Lycke N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr Protoc Immunol. 2001;Chapter 3:Unit 3.19. doi:10.1002/0471142735.im0319s17. Lefrançois L, Lycke N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr Protoc Immunol. 2001;Chapter 3:Unit 3.19. doi:10.​1002/​0471142735.​im0319s17.
23.
go back to reference Gopal R, Birdsell D, Monroy FP. Regulation of chemokine responses in intestinal epithelial cells by stress and Toxoplasma gondii infection. Parasite Immunol. 2011;33:12–24.PubMedCrossRef Gopal R, Birdsell D, Monroy FP. Regulation of chemokine responses in intestinal epithelial cells by stress and Toxoplasma gondii infection. Parasite Immunol. 2011;33:12–24.PubMedCrossRef
24.
go back to reference Stadnyk AW. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol. 2002;16:241–246.PubMed Stadnyk AW. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol. 2002;16:241–246.PubMed
25.
go back to reference Louis K, Netea MG, Carrer DP, et al. Bacterial translocation in an experimental model of multiple organ dysfunctions. J Surg Res. 2013;183:686–694.PubMedCrossRef Louis K, Netea MG, Carrer DP, et al. Bacterial translocation in an experimental model of multiple organ dysfunctions. J Surg Res. 2013;183:686–694.PubMedCrossRef
26.
go back to reference MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull. 2004;71:1–11.PubMedCrossRef MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull. 2004;71:1–11.PubMedCrossRef
27.
go back to reference Nafziger J, Arock M, Guillosson JJ, Wietzerbin J. Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol. 1990;20:113–117.PubMedCrossRef Nafziger J, Arock M, Guillosson JJ, Wietzerbin J. Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol. 1990;20:113–117.PubMedCrossRef
28.
go back to reference Bissonnette EY, Chin B, Befus AD. Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells. Immunology. 1995;86:12–17.PubMedPubMedCentral Bissonnette EY, Chin B, Befus AD. Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells. Immunology. 1995;86:12–17.PubMedPubMedCentral
29.
go back to reference Grootjans J, Lenaerts K, Derikx JP, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol. 2010;176:2283–2291.PubMedCrossRefPubMedCentral Grootjans J, Lenaerts K, Derikx JP, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol. 2010;176:2283–2291.PubMedCrossRefPubMedCentral
30.
go back to reference Huang P, Liu D, Gan X, et al. Mast cells activation contribute to small intestinal ischemia reperfusion induced acute lung injury in rats. Injury. 2012;43:1250–1256.PubMedCrossRef Huang P, Liu D, Gan X, et al. Mast cells activation contribute to small intestinal ischemia reperfusion induced acute lung injury in rats. Injury. 2012;43:1250–1256.PubMedCrossRef
Metadata
Title
Somatostatin Inhibits the Production of Interferon-γ by Intestinal Epithelial Cells During Intestinal Ischemia–Reperfusion in Macaques
Authors
Ling Liu
Qinghua Tan
Bin Hu
Hao Wu
Chunhui Wang
Chengwei Tang
Publication date
01-10-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3177-4

Other articles of this Issue 10/2014

Digestive Diseases and Sciences 10/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.